Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for opioid-induced constipation in critically ill ventilated ICU patients
ISRCTN75305839Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Sep 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in opioid-induced constipation (OIC) comparing Methylnaltrexone with Placebo (2 arms). Primary endpoint: Time to significant rescue-free laxation. Started Sep 2015; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on ISRCTN75305839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN75305839.